FierceBiotech2h
Inflammatix collects FDA clearance for ER sepsis diagnostic test
Inflammatix has secured the FDA’s blessing for its in vitro diagnostic system, aimed at rapidly profiling the body’s response ...
FierceBiotech3h
FDA gives Amylyx green light for phase 1 ALS trial after clinical hold
After raising questions surrounding dosing levels, the FDA has freed Amylyx’s early-stage amyotrophic lateral sclerosis (ALS) ...
FierceBiotech4h
Disc set to spin up confirmatory trial, seek approval after ironing out details with FDA
Disc Medicine has finalized the design of the confirmatory trial for its rare blood disorder drug candidate, adding a ...
FierceBiotech6h
HHS gives Moderna $590M to 'accelerate' bird flu vaccine trials
The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...
FierceBiotech13h
AI drug discoverer’s antiviral reduces COVID in mouse lungs, neutralizes other RNA viruses
Many of the most devastating infectious diseases are caused by RNA viruses and Model Medicines is working on one compound to ...
FierceBiotech9h
InnoCare, Keymed sell ex-China rights for bispecific to RTW-built biotech in $520M deal
U.S.-based Prolium Biosciences has now agreed to pay InnoCare and Keymed $17.5 million in upfront and near-term payments to ...
FierceBiotech9h
Odyssey, Sionna join band of biotechs ready to brave thawing IPO waters in 2025
Odyssey Therapeutics and Sionna Therapeutics have filed IPO paperwork, swelling the pack of startups that will provide an ...